Performance-Driven Payments in Europe -
Kongress / Konferenz
von FORUM Institut für Management GmbH
Payment of high-priced drugs in the UK, BeNeLuxAI, Italy and Germany
- Reimbursement models in the UK for highly specialised technologies - BeNeLuxAI - HTA and pricing coordination - Performance-driven payments in Germany through the GSAV? - Adapting risk-sharing schemes for ATMPs in Italy?Payment of high-priced drugs in the UK, BeNeLuxAI, Italy and Germany - this is where youll get to know current and upcoming pricing models.
The German draft drug law GSAV foresees registries for orphan drugs; first performance-driven payment contracts have already been established. Other countries, such as Italy, have used this pricing model for quite some time.- This conference compiles Europes various tendencies in regard to the payment of high-priced innovative drugs, which are about to enter the European market.- After attending this meeting, you will be aware of the existing payment models and be knowledgeable about the upcoming payment trends in Europe. Lastly, you will get to know possibilities you have in the direct contraction situation with payers.
This conference addresses the needs of employees in the pharmaceutical industry responsible for market access activities in the various national European markets. - Those involved in value-assessment preparation and pricing activities will benefit particularly from this conference.
Termine und Orte